Sandbox Reserved 1092

This Sandbox is Reserved from 25/11/2019, through 30/9/2020 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1091 through Sandbox Reserved 1115.

To get started: Click the edit this page tab at the top. Save the page after each step, then edit it again. show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page. Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc. More help: Help:Editing

5JI1 : Myostatin (GDF8)

spinqualitylabelsall models Caption for this structure Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D This is a default text for your page Myostatin. Click above on edit this page to modify. Be careful with the < and > signs. You may include any references to papers as in: the use of JSmol in Proteopedia or to the article describing Jmol to the rescue. Disease/Research Myostatin is a protein that has a control over muscle development: it is a negative regulator of squeletics muscles. It has a very important role during the development of the animals but also during its whole life. It is a very important protein that is very conserved from zebra fish to humans and so it has to be very well regulated. Indeed, there are many ways that regulates the action of this protein and at many scales. It is a grown factor that is implicated into muscle development in mammals. Myostatin can transmit a message to the nucleus that will promote a gene that lead to the production of ubiquitin. Ubiquitin is a signal of degradation so muscle cells will be destroyed. Indeed, it reduce the mass of the muscle but it also reduces the quantity of Myosin which is very important for the cohesion of muscles and for movement. Indeed Myosin forms filament, and when Myosin filaments associate with Actin and consume ATP it produces muscle movement. Related disease If the quantity of myosin is not well regulated in the human body, it could trigger many muscle related illnesses, especially when there is too much myostatin, as heart disease, liver disease.. We can focus on the example of COPD (Chronic Obstructive Pulmonary Disease) which is a lunch disease. People suffering from this disease have difficulties to breathe because of an obstruction of airflow . Their muscles are not strong enough to help them to breathe the right way and it is called pulmonary cachexia. This disease is also characterized by many muscle complications into the whole body, including a global reduction of muscle mass. It has been proven that a high rate of myostatin quantity in human body can promote this disease. Myostatin has also a role in many metabolisms as in blood glucose: indeed, the more myostatin you have, the more resistant to insulin you are. This could be link with Type 2 diabetes and so obesity because it is an inducer of Phosphotyrosine Interaction Domain containing 1 (PID1) protein [1] in human muscle cells. Indeed, this protein is known for its role into insulin resistance development. A way to cure However, myostatin can also be a way to cure some disease: If myostatin action is inhibited, researchers have noticed that muscular mass increases .Indeed, myostatin and particularly its inhibition can be a solution to cure muscle atrophy disease: let’s focus on the example of OPMD , oculopharyngeal muscular dystrophy: This disease involves that the muscles affected show increased fibrosis and atrophy.This is a late-onset disease, affecting 1 people over 80000. It is characterized by dysphagia and ptosis but also limb weakness when the disease is at a very advanced stage. Researcher have noticed that the inhibition of myostatin, increased the muscle quantity and so it help to reduce the symptoms of OPMD. In this case, a monoclonal antibiotic is injected to mice during 10 weeks and the results show that muscle strength and muscle fiber diameter increased and the expression of the markers of muscle fibrosis reduced. However, myostatin does not cure the disease because there was no change in intranuclear inclusion density which is a characteristic of OPMD spread, so, it only treats the symptom. In other cases, it is also possible to introduce follistatin to block myostatin because they will form a complex and so it will stop myostatin actions. Structural highlights This is a sample scene created with SAT to color by Group, and another to make a transparent representation of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.